South Korea Lymphedema Treatment Market to 2032
Overview
The South Korea Lymphedema Treatment Market is expected to reach a 22.74 USD Million by 2032 and is projected to grow at a CAGR of 10.53% from 2025 to 2032.
Revenue, 2024 (USD Million)
10.39
Forecast, 2032 (USD Million)
22.74
CAGR, 2024 - 2032
10.53%
Report Coverage
South Korea
South Korea Lymphedema Treatment Market 2018-2032 USD Million
South Korea Lymphedema Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 10.39 USD Million
- Projected Market Size (2032): 22.74 USD Million
- CAGR (2025-2032): 10.53%
Key Findings of South Korea Lymphedema Treatment Market
- The South Korea Lymphedema Treatment Market was valued at 10.39 USD Million in 2024.
- The South Korea Lymphedema Treatment Market is likely to grow at a CAGR of 10.53% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Secondary Lymphedema in Type Segment accounted for the largest share of the market with a revenue of 8.19 USD Million
- The fastest growing segment Hospital in End User Segment grew Fastest with a CAGR of 11.34% during the forecast period from 2024 to 2032.
South Korea Lymphedema Treatment Market Scope
South Korea Lymphedema Treatment Market Segmentation & Scope
Route of Administration
- Topical
- Injectable
- Oral
End User
- Others
- Ambulatory Surgical Centers
- Specialty Clinics
- Hospital
Distribution Channel
- Others
- Direct Tender
- Pharmacy Stores
Age Group
- Pediatric
- Geriatric
- Adult
Treatment Type
- Others
- Laser Therapy
- Drug Therapy
- Surgery
- Compression Therapy
Type
- Primary Lymphedema
- Secondary Lymphedema
Affected Area
- Genitalia
- Upper Extremity
- Lower Extremity
South Korea Lymphedema Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2024 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 10.39 USD Million |
| Market Value in 2032 | 22.74 USD Million |
| CAGR (2025-2032) | 10.53% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Route of Administration,End User,Distribution Channel,Age Group,Treatment Type,Type,Affected Area |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 10.39 USD Million in 2024
- Key Country: South Korea, leading in terms of revenue with value of 10.39 USD Million in 2024.
Segments and Scope
-
South Korea Lymphedema Treatment Market to 2032, By Route of Administration
- Oral is the largest segment in South Korea Lymphedema Treatment Market to 2032 with a revenue of 0.51 USD Million in the year 2024.
- Oral is the Fastest growing segment in South Korea Lymphedema Treatment Market to 2032 with a Growth rate of 10.23 % in forecast period 2025-2032.
-
South Korea Lymphedema Treatment Market to 2032, By End User
- Hospital is the largest segment in South Korea Lymphedema Treatment Market to 2032 with a revenue of 5.78 USD Million in the year 2024.
- Hospital is the Fastest growing segment in South Korea Lymphedema Treatment Market to 2032 with a Growth rate of 11.34 % in forecast period 2025-2032.
-
South Korea Lymphedema Treatment Market to 2032, By Distribution Channel
- Pharmacy Stores is the largest segment in South Korea Lymphedema Treatment Market to 2032 with a revenue of 5.55 USD Million in the year 2024.
- Pharmacy Stores is the Fastest growing segment in South Korea Lymphedema Treatment Market to 2032 with a Growth rate of 10.73 % in forecast period 2025-2032.
-
South Korea Lymphedema Treatment Market to 2032, By Age Group
- Adult is the largest segment in South Korea Lymphedema Treatment Market to 2032 with a revenue of 5.57 USD Million in the year 2024.
- Adult is the Fastest growing segment in South Korea Lymphedema Treatment Market to 2032 with a Growth rate of 10.88 % in forecast period 2025-2032.
-
South Korea Lymphedema Treatment Market to 2032, By Treatment Type
- Compression Therapy is the largest segment in South Korea Lymphedema Treatment Market to 2032 with a revenue of 6.84 USD Million in the year 2024.
- Compression Therapy is the Fastest growing segment in South Korea Lymphedema Treatment Market to 2032 with a Growth rate of 10.75 % in forecast period 2025-2032.
-
South Korea Lymphedema Treatment Market to 2032, By Type
- Secondary Lymphedema is the largest segment in South Korea Lymphedema Treatment Market to 2032 with a revenue of 8.19 USD Million in the year 2024.
- Secondary Lymphedema is the Fastest growing segment in South Korea Lymphedema Treatment Market to 2032 with a Growth rate of 10.69 % in forecast period 2025-2032.
-
South Korea Lymphedema Treatment Market to 2032, By Affected Area
- Lower Extremity is the largest segment in South Korea Lymphedema Treatment Market to 2032 with a revenue of 5.62 USD Million in the year 2024.
- Lower Extremity is the Fastest growing segment in South Korea Lymphedema Treatment Market to 2032 with a Growth rate of 10.75 % in forecast period 2025-2032.
South Korea Lymphedema Treatment Market Company Share Analysis
| Company Name |
|
||
| Medi GmBH & Co. KG | |||
| Paul Hartmann AG | |||
| Tactile Medical | |||
| Smith+Nephew | |||
| Cardinal Health | |||
South Korea Lymphedema Treatment Market Geographical Sales Distribution, 2018-2032 USD Million
South Korea Lymphedema Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Lymphedema Treatment Market is segmented based on Segmentation Route of Administration,End User,Distribution Channel,Age Group,Treatment Type,Type,Affected Area.
South Korea Lymphedema Treatment Market was valued at USD 10.39(Revenue in USD Million) in 2024.
South Korea Lymphedema Treatment Market is projected to grow at a CAGR of 10.53% during the forecast period of 2024 to 2032.
The Secondary Lymphedema segment is expected to dominate the South Korea Lymphedema Treatment Market, holding a largest market share of 8.19 USD Million in 2024
South Korea Lymphedema Treatment Market Scope
South Korea Lymphedema Treatment Market Segmentation & Scope
Route of Administration
- Topical
- Injectable
- Oral
End User
- Others
- Ambulatory Surgical Centers
- Specialty Clinics
- Hospital
Distribution Channel
- Others
- Direct Tender
- Pharmacy Stores
Age Group
- Pediatric
- Geriatric
- Adult
Treatment Type
- Others
- Laser Therapy
- Drug Therapy
- Surgery
- Compression Therapy
Type
- Primary Lymphedema
- Secondary Lymphedema
Affected Area
- Genitalia
- Upper Extremity
- Lower Extremity
Frequently Asked Questions
The South Korea Lymphedema Treatment Market is segmented based on Segmentation Route of Administration,End User,Distribution Channel,Age Group,Treatment Type,Type,Affected Area.
South Korea Lymphedema Treatment Market was valued at USD 10.39(Revenue in USD Million) in 2024.
South Korea Lymphedema Treatment Market is projected to grow at a CAGR of 10.53% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Lymphedema Treatment Market for final year is USD 22.74 (USD Million).
South Korea Lymphedema Treatment Market Company Profiling
Frequently Asked Questions
The South Korea Lymphedema Treatment Market is segmented based on Segmentation Route of Administration,End User,Distribution Channel,Age Group,Treatment Type,Type,Affected Area.
South Korea Lymphedema Treatment Market was valued at USD 10.39(Revenue in USD Million) in 2024.
South Korea Lymphedema Treatment Market is projected to grow at a CAGR of 10.53% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Lymphedema Treatment Market for final year is USD 22.74 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.